Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.41 - $0.86 $508 - $1,067
1,241 Added 10.69%
12,852 $5,000
Q1 2024

May 13, 2024

BUY
$0.58 - $0.92 $5,574 - $8,842
9,611 Added 480.55%
11,611 $7,000
Q4 2023

Feb 09, 2024

BUY
$0.78 - $1.67 $103 - $222
133 Added 7.12%
2,000 $1,000
Q3 2023

Nov 09, 2023

BUY
$1.02 - $1.49 $1,904 - $2,781
1,867 New
1,867 $2,000
Q1 2023

May 12, 2023

SELL
$1.36 - $2.3 $5,063 - $8,562
-3,723 Reduced 44.91%
4,566 $8,000
Q4 2022

Feb 08, 2023

SELL
$1.38 - $2.22 $3,089 - $4,970
-2,239 Reduced 21.27%
8,289 $11,000
Q3 2022

Nov 10, 2022

BUY
$1.9 - $2.69 $11,149 - $15,784
5,868 Added 125.92%
10,528 $21,000
Q2 2022

Aug 10, 2022

BUY
$2.39 - $4.15 $6,352 - $11,030
2,658 Added 132.77%
4,660 $11,000
Q1 2022

May 16, 2022

SELL
$2.45 - $4.3 $2,611 - $4,583
-1,066 Reduced 34.75%
2,002 $8,000
Q4 2021

Feb 14, 2022

SELL
$3.75 - $4.67 $3,791 - $4,721
-1,011 Reduced 24.79%
3,068 $12,000
Q3 2021

Nov 15, 2021

SELL
$4.4 - $5.59 $75,196 - $95,533
-17,090 Reduced 80.73%
4,079 $19,000
Q2 2021

Aug 13, 2021

BUY
$3.75 - $6.72 $11,227 - $20,119
2,994 Added 16.47%
21,169 $104,000
Q1 2021

May 12, 2021

SELL
$3.93 - $6.99 $9,872 - $17,558
-2,512 Reduced 12.14%
18,175 $75,000
Q4 2020

Feb 11, 2021

BUY
$3.81 - $4.73 $78,817 - $97,849
20,687 New
20,687 $79,000

Others Institutions Holding PPBT

About PURPLE BIOTECH LTD.


  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $46.5M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.